Initial rate control in atrial fibrillation commonly uses which medication class first?

Initial rate control in atrial fibrillation commonly uses which medication class first?

• A. Calcium channel blockers
• B. Digoxin
• C. Beta blockers
• D. Antiarrhythmic drugs

Answer: (C)

Rate control in atrial fibrillation relies on slowing AV nodal conduction so the ventricles don’t respond to every atrial beat. Blocking beta-adrenergic receptors achieves this quickly and reliably by reducing sympathetic stimulation to the heart, which directly lowers the AV node’s conduction velocity and its tendency to fire rapidly. Because beta-blockers are titratable, work well during rest and activity, and tend to be well tolerated in many patients, they are the most common first choice for initial rate control. Digoxin can slow the heart rate, but it acts more slowly and is less effective during exercise or stress; it’s often reserved for patients who are sedentary or have heart failure with reduced ejection fraction as an adjunct. Calcium channel blockers also reduce AV nodal conduction and are useful if beta-blockers are contraindicated, but they can cause more hypotension or negative inotropy and are avoided in patients with reduced EF. Antiarrhythmic drugs aim more at restoring or maintaining rhythm rather than controlling rate, so they’re not first-line for rate control.

Rate control in atrial fibrillation relies on slowing AV nodal conduction so the ventricles don’t respond to every atrial beat. Blocking beta-adrenergic receptors achieves this quickly and reliably by reducing sympathetic stimulation to the heart, which directly lowers the AV node’s conduction velocity and its tendency to fire rapidly. Because beta-blockers are titratable, work well during rest and activity, and tend to be well tolerated in many patients, they are the most common first choice for initial rate control.

Digoxin can slow the heart rate, but it acts more slowly and is less effective during exercise or stress; it’s often reserved for patients who are sedentary or have heart failure with reduced ejection fraction as an adjunct. Calcium channel blockers also reduce AV nodal conduction and are useful if beta-blockers are contraindicated, but they can cause more hypotension or negative inotropy and are avoided in patients with reduced EF. Antiarrhythmic drugs aim more at restoring or maintaining rhythm rather than controlling rate, so they’re not first-line for rate control.